Acer MedicalROCO:6857 52 ROA % is -13.96% as of Dec. 2025. GuruFocus rates ROCO:6857 with a GF Score™ of 52/100 and a GF Value™ of NT$262.01 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 684 Healthcare Providers & Services companies, Acer Medical ranks worse than 79.68% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Acer Medical's annualizedNet Income for the quarter that ended in Dec. 2025 was NT$-29.08 Mil.
Acer Medical's average Total Assets over the quarter that ended in Dec. 2025 was NT$208.36 Mil. Therefore, Acer Medical's annualized ROA % for the quarter that ended in Dec. 2025 was -13.96%.
The historical rank and industry rank for Acer Medical's ROA % or its related term are showing as below:
ROCO:6857'
s ROA % Range Over the Past 10 Years
Min: -26.22 Med: -13.89 Max: -11.25
Current: -13.84
During the past 7 years, Acer Medical's highest ROA % was -11.25%. The lowest was -26.22%. And the median was -13.89%.
ROCO:6857's ROA % is ranked worse than 79.68% of 684
companies
in the Healthcare Providers & Services industry
Industry Median: 1.78
vs ROCO:6857: -13.84
Acer Medical (ROCO:6857) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Acer Medical ROA % Related Terms
Acer Medical ROA % Historical Data
* Premium members only.
The historical data trend for Acer Medical's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Acer Medical's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acer Medical ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Acer Medical's ROA % distribution charts can be found below:
* The bar in red indicates where Acer Medical's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Acer Medical (ROCO:6857) has a ROA % of -13.96% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Acer Medical and its competitors. According to the industry distribution chart, Acer Medical ranks #545 out of 684 companies in the Healthcare Providers & Services industry, placing it in the top 79.7%.
Is Acer Medical's ROA % too high?
Acer Medical's current ROA % is -13.96%. Based on the distribution chart, Acer Medical ranks #545 out of 684 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Acer Medical has a GF Score™ of 52/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acer Medical's ROA % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Acer Medical ranks #545 out of 684 companies for ROA %. This places Acer Medical in the lower half of its industry. The industry median ROA % is 1.78. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.78, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Acer Medical and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acer Medical's current ROA % is -13.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acer Medical stock overvalued right now?
Based on GuruFocus' analysis, Acer Medical (ROCO:6857) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$262.01, compared to a current price of NT$93.00 — trading 64.5% below its estimated fair value. The current ROA % is -13.96%. Acer Medical's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Acer Medical (ROCO:6857), the current ROA % is -13.96% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acer Medical (ROCO:6857) Overvalued in 2026?
Based on GuruFocus' analysis, Acer Medical stock appears to be undervalued.
The current stock price of NT$93.00 is trading 64.5% below its estimated GF Value™ of NT$262.01.
GuruFocus considers Acer Medical to be Significantly Undervalued.
Key valuation signals for ROCO:6857:
ROA %: -13.96%
GF Value™: NT$262.01 vs. price of NT$93.00 (64.5% below fair value)
No single metric tells the full story. See the ROCO:6857 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acer Medical Inc focuses on improving human health and well-being through artificial intelligence. It focuses on applying artificial intelligence and large data to the area of healthcare. Acer Medical is capable of designing, developing, commercializing, as well as implementing AI solutions in medical institutions.
52GF Score
Get the complete analysis for ROCO:6857
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6857 has been successfully added to your 
